PATENT CLAIM ANALYSIS

Application Number: 16099486
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["544", "351000"]

Abstract:
The present application belongs to the field of energetic compounds, and particularly relates to the use of a perovskite-type compound ABX 3  as an energetic material. As a finding of the present application, the structural characteristics of the perovskite type enables the type of compound to be highly stable, thus overcoming the unsafety of an explosive having poor stability in the prior art. Meanwhile, the structural characteristics of the compound, such as rich energetic ligands, as well as the alternately arranged oxidizing energetic anions and reducing organic cations in the space, endow the compound with excellent performance on instantaneously releasing energy at detonation. The resulting three-dimensional structure allows the compound to not only have an energetic material effect but also overcome shortcomings of some existing energetic materials.

Claim (Index 9):
Use of a compound obtainable by the following method as an energetic material:\n adding A component, B component and X component into a liquid reaction system in any order, for reaction; the liquid reaction system is preferably polar solvent capable of dissolving the A component, the B component and the X component; preferably, the compound is obtained by the following steps 1 to 3: 1) adding the A component into the polar solvent, then adding the X component, and uniformly stirring; 2) dissolving the B component into the polar solvent; 3) mixing a solution obtained in step 1) with a solution obtained in step 2) for reaction; wherein the A component is at least one, two or more of 1,4-diazabicyclo[2.2.2]octane or a derivative thereof, pyrazine or a derivative thereof, piperazine or a derivative thereof, 1,4-diazabicyclo[2.2.2]octane 1-oxide or a derivative thereof, 1,4-diazabicyclo[2.2.2]octane 1,4-dioxide or a derivative thereof, organic salt containing a 1,4-diazabicyclo[2.2.2]octane-1,4-diium or a derivative thereof, organic salt containing a pyrazine-1,4-diium or a derivative thereof, organic salt containing a piperazine-1,4-diium or a derivative thereof, organic salt containing a 1-hydroxy-1,4-diazabicyclo[2.2.2]octane-1,4-diium or a derivative thereof, and organic salt containing 1,4-dihydroxy-1,4-diazabicyclo[2.2.2]octane-1,4-diium or derivative(s) thereof; and more preferably, the A component is selected from one, two or more of the 1,4-diazabicyclo[2.2.2]octane or the derivative thereof, the 1,4-diazabicyclo[2.2.2]octane 1-oxide or the derivative thereof, and the 1,4-diazabicyclo[2.2.2]octane 1,4-dioxide or the derivative thereof; the B component contains a cation, and the cation is selected from one, two or more of alkali metal ions and NH 4 + ; more preferably, the B component is selected from one, two or more of Na + , K + , Rb +  and NH 4 + ; preferably, the B component is at least one of ammonium salt, sodium salt, potassium salt, rubidium salt, cesium salt, ammonium alkali, sodium alkali, potassium alkali, rubidium alkali and cesium alkali; the X component is at least one selected from a halogen-containing energetic acids and halogen-containing energetic salts, preferably, is one, two or more selected from halogen-containing energetic ligands ClO 4 \u2212 , BrO 4 \u2212  and IO 4 \u2212 , and more preferably ClO 4 \u2212 ; preferably, the polar solvent is one, two or more selected from water, ethanol and methanol.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 98.0
- Lexical Diversity: 1.68293
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15493371', '15169859', '15668390', '12753526', '15018179']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6713726616517832
- 35 USC 102 Novelty (BERT): 0.5066437135490459
- Combined Prediction Score: 0.6548997668415095
- Mean Citation Score: 179.56433999999996
- Max Citation Score: 189.32019
- Similarity Product: 113.853475637632

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test